サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1791614

ライフサイエンス企業向けデータ収益化ソリューションの世界市場

Data Monetization Solutions for Life Science Companies

出版日
ページ情報
英文 158 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
ライフサイエンス企業向けデータ収益化ソリューションの世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ライフサイエンス企業向けデータ収益化ソリューションの世界市場は2030年までに11億米ドルに達する見込み

2024年に4億1,690万米ドルと推定されるライフサイエンス企業向けデータ収益化ソリューションの世界市場は、分析期間2024-2030年にCAGR 17.5%で成長し、2030年には11億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである間接データ収益化は、CAGR 20.1％を記録し、分析期間終了時には7億4,480万米ドルに達すると予測されます。ダイレクトデータマネタイゼーションセグメントの成長率は、分析期間中CAGR13.1%と推定されます。

米国市場は1億960万米ドルと推定、中国はCAGR16.4％で成長予測

米国のライフサイエンス企業向けデータ収益化ソリューション市場は、2024年に1億960万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億6,770万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは16.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ16.5％と14.8％と予測されています。欧州では、ドイツがCAGR約12.5%で成長すると予測されています。

世界のライフサイエンス企業向けデータ収益化ソリューション- 主要動向と成長促進要因のまとめ

データマネタイゼーションがライフサイエンス業界を変革する理由

製薬会社、バイオテクノロジー企業、臨床研究機関などのライフサイエンス企業は、臨床試験、ゲノミクス、創薬、患者モニタリングを通じて膨大な量のデータを生み出しています。データの収益化によって、これらの企業は新たな収益源を確保し、研究開発（R&D）を最適化し、AI主導の洞察によって患者の転帰を改善することができます。匿名化・構造化されたデータセットを活用することで、ライフサイエンス企業は医薬品開発を加速し、精密医療を強化し、個別化ヘルスケアソリューションのイノベーションを推進することができます。

デジタルヘルス、リアルワールドエビデンス（RWE）の活用、AIを活用した診断へのシフトは、データ収益化戦略の必要性をさらに高めています。ライフサイエンス企業は、医療提供者、支払者、規制当局との戦略的協業を通じて、意思決定の改善、市場動向の把握、臨床研究の効率化にデータ主導の知見を活用しています。また、クラウドベースの分析プラットフォームやブロックチェーン対応のデータマーケットプレースの採用が進むことで、安全でコンプライアンスに準拠したデータ取引が促進され、ライフサイエンスデータの倫理的な収益化が実現しています。

ライフサイエンスデータの収益化における最新のイノベーションとは？

AI、機械学習（ML）、データ相互運用性の進歩は、ライフサイエンスにおけるデータ収益化の能力を大幅に向上させました。最も注目すべきイノベーションの1つは、AIモデルが機密性の高い患者情報を公開することなく、複数の機関に分散したデータセットを分析できるようにする連携学習です。このアプローチにより、データプライバシー規制の遵守を維持しながら、創薬、バイオマーカー同定、個別化治療計画のコラボレーションが向上しています。

もう一つのブレークスルーは、匿名化されたデータセットを研究目的で安全に取引できる、トークン化された医療データ交換の開発です。ブロックチェーン技術は、透明性、データの完全性、アクセス制御を確保し、ライフサイエンス企業がゲノム、プロテオミクス、臨床試験データを許可された利害関係者と共有することを可能にしています。さらに、AIを活用したデータ整合化ツールは、異種データセットの統合を最適化し、企業が異種ソースから実用的な洞察を導き出せるようにしています。合成データ（プライバシーを損なうことなく実際の患者情報を模倣したAIが生成したデータセット）の使用も、データ収益化のための倫理的かつ規制に準拠した代替手段として支持を集めています。

市場動向と規制政策はライフサイエンスデータの収益化にどのような影響を与えているか？

エビデンスに基づく医療、リアルワールドデータ（RWD）の活用、AI主導の研究が重視されるようになったことで、ライフサイエンス分野でのデータ収益化戦略の採用が加速しています。ライフサイエンス企業はヘルスケア機関、学術機関、AI企業と提携し、大規模なデータ分析を活用して薬効や患者層別化の改善に取り組んでいます。

HIPAA、GDPR、FDAのReal-World Evidence Programといった規制の枠組みは、データ収益化方針を大きく形成しています。企業は医療データ資産を商業化しながらコンプライアンスを確保するため、データの匿名化、患者の同意、倫理的使用に関する厳格なガイドラインを遵守しなければならないです。さらに、データガバナンス・イニシアチブとFHIR（Fast Healthcare Interoperability Resources）などの相互運用性標準の台頭により、さまざまな利害関係者間でのシームレスなデータ共有と収益化が促進されています。

ライフサイエンス企業向けデータ収益化ソリューション市場の成長を牽引しているのは？

ライフサイエンス企業のデータ収益化市場の成長は、AI主導型アナリティクスの利用拡大、ゲノムおよび創薬の進歩、実世界のデータインサイトに対する需要の高まりによってもたらされています。個別化医療とプレシジョン・ヘルスケアの台頭は、標的治療と治療の最適化に役立つ構造化された高品質のデータセットの必要性をさらに高めています。

最終用途の拡大も重要な要素で、臨床研究、ファーマコビジランス、集団健康管理でデータの収益化が活用されています。AIを活用したデータマーケットプレース、クラウドベースのアナリティクス、ブロックチェーンで保護されたデータトランザクションの統合により、導入が加速しています。さらに、製薬企業、バイオテクノロジー新興企業、データ・セキュリティ企業間の戦略的提携がイノベーションを促進し、ライフサイエンス・データ収益化ソリューションがコンプライアンスと倫理的整合性を維持しながら業界のニーズに合致するようになっています。

セグメント

タイプ（間接データ収益化、直接データ収益化）、展開（クラウド展開、オンプレミス展開）、施設規模（大規模施設、中小規模施設）

調査対象企業の例

  • Accenture plc
  • Cerner Corporation
  • Cisco Systems, Inc.
  • GE Healthcare
  • Google LLC
  • Infosys Limited
  • McKesson Corporation
  • Medidata Solutions
  • Microsoft Corporation
  • OpenText Corporation
  • Oracle Corporation
  • Particle Health, Inc.
  • Salesforce, Inc.
  • SAP SE
  • SAS Institute Inc.
  • Scientist.com
  • Siemens AG
  • Snowflake Inc.
  • TIBCO Software Inc.
  • Veeva Systems Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP30367

Global Data Monetization Solutions for Life Science Companies Market to Reach US$1.1 Billion by 2030

The global market for Data Monetization Solutions for Life Science Companies estimated at US$416.9 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 17.5% over the analysis period 2024-2030. Indirect Data Monetization, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$744.8 Million by the end of the analysis period. Growth in the Direct Data Monetization segment is estimated at 13.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$109.6 Million While China is Forecast to Grow at 16.4% CAGR

The Data Monetization Solutions for Life Science Companies market in the U.S. is estimated at US$109.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$167.7 Million by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.5% and 14.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global Data Monetization Solutions for Life Science Companies - Key Trends & Growth Drivers Summarized

Why Is Data Monetization Transforming the Life Sciences Industry?

Life science companies, including pharmaceutical firms, biotechnology enterprises, and clinical research organizations, generate vast amounts of data through clinical trials, genomics, drug discovery, and patient monitoring. Data monetization is enabling these organizations to unlock new revenue streams, optimize research and development (R&D), and improve patient outcomes through AI-driven insights. By leveraging anonymized and structured datasets, life science firms can accelerate drug development, enhance precision medicine, and drive innovation in personalized healthcare solutions.

The shift toward digital health, real-world evidence (RWE) utilization, and AI-powered diagnostics has further intensified the need for data monetization strategies. Through strategic collaborations with healthcare providers, payers, and regulatory agencies, life science companies are leveraging data-driven insights to improve decision-making, identify market trends, and streamline clinical research. The growing adoption of cloud-based analytics platforms and blockchain-enabled data marketplaces is also facilitating secure and compliant data transactions, ensuring ethical monetization of life science data.

What Are the Latest Innovations in Life Sciences Data Monetization?

Advancements in AI, machine learning (ML), and data interoperability have significantly enhanced the capabilities of data monetization in life sciences. One of the most notable innovations is federated learning, which allows AI models to analyze decentralized datasets across multiple institutions without exposing sensitive patient information. This approach is improving collaboration in drug discovery, biomarker identification, and personalized treatment planning while maintaining compliance with data privacy regulations.

Another breakthrough is the development of tokenized health data exchanges, where anonymized datasets can be securely traded for research purposes. Blockchain technology is ensuring transparency, data integrity, and controlled access, enabling life science companies to share genomic, proteomic, and clinical trial data with authorized stakeholders. Additionally, AI-powered data harmonization tools are optimizing the integration of heterogeneous datasets, allowing companies to derive actionable insights from disparate sources. The use of synthetic data-AI-generated datasets that mimic real patient information without compromising privacy-is also gaining traction as an ethical and regulatory-compliant alternative for data monetization.

How Are Market Trends and Regulatory Policies Influencing Life Science Data Monetization?

The increasing emphasis on evidence-based medicine, real-world data (RWD) utilization, and AI-driven research has propelled the adoption of data monetization strategies in the life sciences sector. Life science companies are partnering with healthcare organizations, academic institutions, and AI firms to leverage large-scale data analytics for improved drug efficacy and patient stratification.

Regulatory frameworks such as HIPAA, GDPR, and the FDA’s Real-World Evidence Program have significantly shaped data monetization policies. Companies must adhere to strict guidelines on data anonymization, patient consent, and ethical usage to ensure compliance while commercializing health data assets. Additionally, the rise of data governance initiatives and interoperability standards such as FHIR (Fast Healthcare Interoperability Resources) has facilitated seamless data sharing and monetization across different stakeholders.

What Is Driving the Growth of the Data Monetization Solutions for Life Science Companies Market?

The growth in the data monetization market for life science companies is driven by the increasing use of AI-driven analytics, advancements in genomics and drug discovery, and the growing demand for real-world data insights. The rise of personalized medicine and precision healthcare has further fueled the need for structured, high-quality datasets that can inform targeted therapies and treatment optimization.

End-use expansion is another key factor, with data monetization being leveraged in clinical research, pharmacovigilance, and population health management. The integration of AI-powered data marketplaces, cloud-based analytics, and blockchain-secured data transactions is accelerating adoption. Additionally, strategic partnerships between pharmaceutical firms, biotech startups, and data security companies are fostering innovation, ensuring that life science data monetization solutions align with industry needs while maintaining compliance and ethical integrity.

SCOPE OF STUDY:

The report analyzes the Data Monetization Solutions for Life Science Companies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Indirect Data Monetization, Direct Data Monetization); Deployment (Cloud Deployment, On-Premises Deployment); Facility Size (Large Facilities, Small and Medium Facilities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

  • Accenture plc
  • Cerner Corporation
  • Cisco Systems, Inc.
  • GE Healthcare
  • Google LLC
  • Infosys Limited
  • McKesson Corporation
  • Medidata Solutions
  • Microsoft Corporation
  • OpenText Corporation
  • Oracle Corporation
  • Particle Health, Inc.
  • Salesforce, Inc.
  • SAP SE
  • SAS Institute Inc.
  • Scientist.com
  • Siemens AG
  • Snowflake Inc.
  • TIBCO Software Inc.
  • Veeva Systems Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Data Monetization Solutions for Life Science Companies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Explosion of Omics, Clinical, and Real-World Data Throws the Spotlight on Data Monetization as a Strategic Growth Lever in Life Sciences
    • Rising R&D Costs and Lengthening Drug Development Timelines Strengthen the Business Case for Commercializing Proprietary Data Assets
    • Increased Adoption of Real-World Evidence (RWE) and Real-World Data (RWD) for Regulatory Submissions Expands Monetization Opportunities
    • Growing Demand for Patient-Centric and Precision Medicine Models Drives the Need for High-Granularity, Monetizable Datasets
    • Integration of Clinical Trial, Genomic, and Longitudinal Health Data Enables Development of High-Value, Multi-Dimensional Data Products
    • Digital Transformation Across Pharma and Biotech Spurs Investment in Data Lakes, Marketplaces, and Data-as-a-Service (DaaS) Platforms
    • Emergence of AI-Driven Drug Discovery Models Creates Demand for Proprietary, High-Quality Labeled Datasets
    • Post-Approval Market Surveillance and Pharmacovigilance Programs Leverage Monetized Data Streams from Internal and Partner Systems
    • Expansion of Companion Diagnostics and Biomarker Discovery Initiatives Fuels Commercialization of Clinical and Lab Data Assets
    • Integration of EHR, Claims, Imaging, and Wearable Data Sources Increases Scope for Licensing and Data Sharing Agreements
    • Shift Toward Outcome-Based and Risk-Sharing Agreements Drives Life Sciences Companies to Monetize Insights-Driven Data Products
    • Adoption of Federated Learning and Privacy-Preserving Analytics Enables Data Sharing Without Compromising IP or Patient Privacy
    • Rising Regulatory Pressure for Transparent and Explainable AI Strengthens Demand for Traceable, Governed Data Sources
    • Growth of Digital Therapeutics and Connected Health Devices Adds New Monetizable Data Streams from Patient Usage Patterns
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Data Monetization Solutions for Life Science Companies Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Indirect Data Monetization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Indirect Data Monetization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Direct Data Monetization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Direct Data Monetization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cloud Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Cloud Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for On-Premises Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for On-Premises Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Large Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Large Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Small & Medium Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Small & Medium Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • JAPAN
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • CHINA
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • EUROPE
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • FRANCE
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 48: France Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • GERMANY
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 54: Germany Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Germany 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • ITALY
    • TABLE 60: Italy Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Italy 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • UNITED KINGDOM
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 66: UK Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: UK 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 68: UK Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 72: Rest of Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 78: Asia-Pacific Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Asia-Pacific 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 84: Rest of World Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of World 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030

IV. COMPETITION